These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39001907)

  • 1. The role of quercetin in ameliorating bleomycin-induced pulmonary fibrosis: insights into autophagy and the SIRT1/AMPK signaling pathway.
    Li Z; Jiao Y; Wu Z; Liu H; Li Y; Cai Y; Wei W; Cao F
    Mol Biol Rep; 2024 Jul; 51(1):795. PubMed ID: 39001907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of lung protection of Sanghuangporus sanghuang through TLR4/NF-κB/MAPK, keap1/Nrf2/HO-1, CaMKK/AMPK/Sirt1, and TGF-β/SMAD3 signaling pathways mediating apoptosis and autophagy.
    Chien LH; Deng JS; Jiang WP; Chou YN; Lin JG; Huang GJ
    Biomed Pharmacother; 2023 Sep; 165():115080. PubMed ID: 37392658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of bleomycin-induced oxidative stress and pulmonary fibrosis by N-acetylcysteine in rats via AMPK/SIRT1/NF-κβ.
    Mansour HH; Omran MM; Hasan HF; El Kiki SM
    Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1943-1952. PubMed ID: 32658336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy.
    Qi J; Wu Y; Guo Z; Zhu S; Xiong J; Hu F; Liang X; Ye X
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):132896. PubMed ID: 38851619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nobiletin alleviates macrophage M2 polarization by activating AMPK-mTOR-mediated autophagy in pulmonary fibrosis mice.
    Cheng Y; Mei X; Shao W; Zheng J; Yin X; Zhang Q; Li J; Zhao P
    Int Immunopharmacol; 2024 Sep; 139():112792. PubMed ID: 39079195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.
    Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H
    BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD
    Guo F; Xu F; Li S; Zhang Y; Lv D; Zheng L; Gan Y; Zhou M; Zhao K; Xu S; Wu B; Deng Z; Fu P
    Eur J Med Res; 2024 Jan; 29(1):68. PubMed ID: 38245795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bryodulcosigenin attenuates bleomycin-induced pulmonary fibrosis via inhibiting AMPK-mediated mesenchymal epithelial transition and oxidative stress.
    Ding Y; Wang L; Liu B; Ren G; Okubo R; Yu J; Zhang C
    Phytother Res; 2022 Oct; 36(10):3911-3923. PubMed ID: 35794782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating rutin as a potential transforming growth factor-β type I receptor antagonist for the inhibition of bleomycin-induced lung fibrosis.
    Karunarathne WAHM; Lee KT; Choi YH; Kang CH; Lee MH; Kim SH; Kim GY
    Biofactors; 2024; 50(3):477-492. PubMed ID: 38006284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geneticin ameliorates pulmonary fibrosis by attenuating the TGF-β/Smad via modulating AMPK/SIRT1 signaling.
    Tirunavalli SK; Andugulapati SB
    Life Sci; 2024 Jun; 346():122626. PubMed ID: 38614295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.
    Zhao H; Qin HY; Cao LF; Chen YH; Tan ZX; Zhang C; Xu DX
    Toxicol Lett; 2015 Jan; 232(1):213-20. PubMed ID: 25455454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT).
    Rong L; Wu J; Wang W; Zhao RP; Xu XW; Hu D
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2144-50. PubMed ID: 27249616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin induces pro-apoptotic autophagy via SIRT1/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro.
    Guo H; Ding H; Tang X; Liang M; Li S; Zhang J; Cao J
    Thorac Cancer; 2021 May; 12(9):1415-1422. PubMed ID: 33709560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
    Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
    Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization.
    Nguyen QC; Nguyen HA; Pham TA; Tran VT; Nguyen TD; Pham DV
    J Ethnopharmacol; 2024 Aug; 330():118226. PubMed ID: 38670401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aqueous extract of Epimedium sagittatum mitigates pulmonary fibrosis in mice].
    Wang R; Hou FY; Zeng MN; Zhang BB; Zhang QQ; Xie SS; Feng WS; Zheng XK
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5612-5622. PubMed ID: 38114154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
    Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
    J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.